CALIFORNIA GOV. WILSON (R) VETOES DRUG DOSAGE FORM ANTI- SUBSTITUTION
CALIFORNIA GOV. WILSON (R) VETOES DRUG DOSAGE FORM ANTI- SUBSTITUTION bill by returning SB 1427 unsigned to the legislature on Sept. 15. Wilson cited the effect that the bill would have had on professional judgment of pharmacists and physicians as one of the key reasons for the veto. SB 1427 would have prohibited substitutions of prescription drugs in which two products incorporate the same active ingredient but have different release mechanisms.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth